Not exact matches
Sen and his colleagues tested sucralose, a popular low - calorie sweetener,
on stem
cells —
cells that could change into mature fat, muscle,
cartilage or bone
cells — taken from human fat tissue.
By monitoring stem
cell differentiation
on gels that mimic the stiffness and nanofibrous structure of biological tissue, researchers have identified the specific molecules that stem
cells use when selecting bone and
cartilage fates.
The teams are currently working
on the fabrication of 3D structures from the blend suitable for implantation in patient joints with future studies focusing
on understanding the peculiar interactions between the blend and stem
cells towards refining the quality of regenerated
cartilage.
Cell - based therapies could offer a way to treat
cartilage injuries before the ultimate damage of osteoarthritis
on articular
cartilage.
RAR molecules are abundant
on the surface of
cartilage cells, hence the positive targeted response of the drug.
The team also tested hydrogel's effects
on cells from
cartilage and joints, finding that it appeared to be safe.
Researchers at the La Jolla Institute for Allergy and Immunology, in collaboration with colleagues the University of California, San Diego, identified a novel drug target for the treatment of rheumatoid arthritis that focuses
on the
cells that are directly responsible for the
cartilage damage in affected joints.
Cells in the early embryo are thus directed to make a decision to either form bone or
cartilage, depending
on where they are.
The findings suggest that reductions in the number of
cartilage - producing
cells, and greater risk for osteoarthritis, may be driven not just by lower adenosine levels but also by lower levels of the protein
on the surface of chondrocytes designed to receive and pass
on adenosine's signal.
The study is the first, say its authors, to provide evidence that adenosine, a biochemical at the heart of human cellular function, plays another crucial role — keeping
on hand a steady number of healthy chondrocytes, the
cells that make and sustain
cartilage.
This could let synthetic biologists generate tissues
on demand, such as insulin - producing β
cells, or
cartilage - producing chondrocytes.
The two
cell types formed structures reminiscent of bone growth plates —
cartilage on one side, bone and marrow
on the other, they report online 6 September in the Proceedings of the National Academy of Sciences.
In other words, adult stem
cells can differentiate (turn into) skin, bone and
cartilage, in addition to secreting other beneficial growth and repair factors which can «turn
on» the body's native ability to repair itself.
Additionally, ERCs were reported to be able to differentiate into, or become,
cells from the three different germ layers (see the previous post
on MSCs for more details): mesoderm (muscle, bone, fat,
cartilage, and endothelial
cells), ectoderm (neurons), and endoderm (liver, pancreas, and lung
cells)(Meng et al., 2007; Patel et al., 2008).
A hand - held «bio pen» fed with bioink that will allow surgeons to 3D print patient - specific
cartilage cells on to knee and hip joints to repair and replace
cartilage which is the «shock absorber» for our long bones.
On the other hand, there are many other tissues — notably, the kidney and articular
cartilage — where p16Ink4a - expressing senescent
cells appear to be a contributing factor to human and murine degenerative aging, but which were not evaluated in treated or control mice in this study, and it would be of interest to see the effects of ablation of p16Ink4a - positive senescent
cells.
Based
on previous protocols [5, 6] they have now created a 3D protocol for chondrogenic lineage differentiation via the generation of a putative chondrogenic progenitor
cell population, and have found that using this protocol C - iPSCs can be readily differentiated into
cartilage in a manner comparable to that of mature chondrocytes [7].
The new Science study focused
on the K36 mutation, which blocks the specialization in the type of stem
cell that can form
cartilage, bone and fat.
The function of the tiny «energy engines» — mitochondria — inside every
cell is improved, whether joint
cartilage cells or retinal
cells, so the
cells which depend
on those mitochondria for energy can function more normally again.
In the US, companies like RecyteCorp are
on the cutting edge of developing injectable stem
cell treatments to manage everything from regrowing spinal chord
cells to erasing
cartilage pain.
Recent studies
on cartilage, which is found abundantly in homemade broth, show it supports the immune system in a variety of ways; it's a potent normalizer, true biological response modifier, activator of macrophages, activator of Natural Killer (NK)
cells, rouser of B lymphocytes, and releaser of Colony Stimulating Factor.
Stem
cell therapy offers the possibility of using these stem
cells to grow into replacements for injured or diseased tissues such as bone,
cartilage, muscle, nerves, and so
on.
Research done
on cartilage transplantation and gene
cell therapy in the Orthopaedics Laboratory has been utilized in the treatment of knee injuries in people.
On radiographs we are looking for flattening of joint surfaces, lucency (dark spots) or sclerosis (white spots) in the bone just under the
cartilage, osteophytes (new bone
cells), joint effusion (fluids) and joint mice.
Glucosamine works by acting
on living
cartilage cells, so it is most effective when used early in the course of arthritis, before the joint damage is extensive.